Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
NCT05976906
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
BIOLOGICAL:
Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
Sponsor
Zhejiang University